Cardio Diagnostics Holdings Free Cash Flow (FCF) History (CDIO)

Cardio Diagnostics Holdings reported −$5.9M in free cash flow for fiscal 2025, a decrease of $706,281 from the previous fiscal year, with a free cash flow margin of −39893.09%.

View full Cardio Diagnostics Holdings company overview

Cardio Diagnostics Holdings free cash flow by year

Cardio Diagnostics Holdings annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20252025-12-31−$5.9M−$706,281−39893.09%
20242024-12-31−$5.2M$1.0M−14926.54%
20232023-12-31−$6.2M−36612.00%

Cardio Diagnostics Holdings free cash flow growth trends

Cardio Diagnostics Holdings's latest reported quarter, Q2 2026, generated −$1.3M in free cash flow, an increase of $247,797 year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Cardio Diagnostics Holdings filings at SEC.gov ↗